文献速递骨质疏松与钙磷/甲状旁腺

5种杂合钙敏感受体变异所致钙稳态紊乱的异质性起源

Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究在HEK293T细胞中检测5种杂合CASR变异(FHH1相关Y63C、I81T、Q459R、W818stop及ADH1相关R955stop)的表达与功能,发现Y63C和I81T细胞表面表达及钙反应性显著降低,Q459R表现野生型样,W818stop细胞表面表达缺失,R955stop表面表达及钙效能轻度增加;不同变体对正向变构调节剂反应不同。

要点

  • Y63C和I81T变异降低细胞表面表达与钙反应性,Q459R表达功能类似野生型。
  • W818stop消除细胞表面表达,R955stop增加表面表达与钙效能。
  • 拟钙剂效果因CASR变异类型而异。

核心结论

  • 5种CASR变异的分子表型与患者临床表型一致,但CASR变异所致钙稳态紊乱的分子起源多样,拟钙剂疗效可能因特定变异而异。

研究设计与样本

  • 在HEK293T细胞中表达野生型及5种杂合CASR变异(FHH1:Y63C、I81T、Q459R、W818stop;ADH1:R955stop),用酶联免疫吸附法测定总表达与细胞表面表达,并在2种功能试验中鉴定受体药理特性。

主要发现

  • 细胞外域Y63C和I81T变异导致细胞表面表达与钙反应性显著降低,Q459R表现为野生型样表达与功能特性。
  • 7次跨膜域截短W818stop消除细胞表面表达,而细胞内羧基端R955stop较野生型CaSR表面表达及钙效能轻度增加。
  • 正向变构调节剂效果因变体而异:Y63C和I81T介导的钙信号被7TMD结合正向变构调节剂(NPS R-568和evocalcet)显著增强,但ECD结合正向变构调节剂(etelcalcetide和Nb4)无此作用;Q459R和R955stop信号被全部4种正向变构调节剂强烈增强。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The human calcium-sensing receptor (CaSR) plays a key role in calcium homeostasis, and most identified CASR variants are associated with hypercalcemic and hypocalcemic disorders. OBJECTIVE: Here we characterized the pharmacological implications of 5 heterozygous CASR variants from individuals with familial hypocalciuric hypercalcemia 1 (FHH1: Y63C, I81T, Q459R, W818stop) or autosomal dominant hypocalcemia 1 (ADH1: R955stop). METHODS: Total and cell surface expression levels of wild-type (WT) and variant CaSRs expressed in human embryonic kidney 293T (HEK293T) cells were determined using enzyme-linked immunosorbent assay, and the pharmacological properties of the receptors were delineated in 2 functional assays. RESULTS: The Y63C and I81T variations in the extracellular domain (ECD) of CaSR yielded markedly reduced cell surface expression and Ca2+ responsiveness, while Q459R displayed WT-like expression and functional properties. Truncation of the 7-transmembrane domain (7TMD) in W818stop eliminated cell surface expression, whereas R955stop in the intracellular carboxy-terminal yielded modestly increased surface expression and Ca2+ potency compared with WT CaSR. Interestingly, the effectiveness of positive allosteric modulators (PAMs) at the variants varied. Ca2+-mediated signaling through Y63C and I81T was significantly augmented by 7TMD-binding PAMs (NPS R-568 and evocalcet) but not by ECD-binding PAMs (etelcalcetide and Nb4), whereas signaling through Q459R and R955stop were robustly potentiated by all four PAMs. CONCLUSION: While the molecular phenotypes exhibited by the 5 CaSR variants concord with the clinical phenotypes in individuals harboring them, CASR variant-induced calcium homeostasis disorders clearly arise from diverse molecular origins, and the effectiveness of calcimimetics in these disorders could differ depending on the specific variants.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Du W, Boisen IM, Rahman SN, et al. Heterogeneous Origins of Calcium Homeostasis Disorders Arising From 5 Heterozygous Calcium-Sensing Receptor Variants. J Clin Endocrinol Metab. 2025. PMID: 39413244. doi:10.1210/clinem/dgae735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。